Journal
RHEUMATOLOGY INTERNATIONAL
Volume 30, Issue 6, Pages 817-819Publisher
SPRINGER
DOI: 10.1007/s00296-009-1000-x
Keywords
Dermatopolymyositis; Polyvalent immunoglobulin; Anti-CD20; Immunotherapy
Categories
Ask authors/readers for more resources
We report on a 44-year-old woman affected by dermatopolymyositis resistant to conventional therapies who experienced long-term clinical improvement and remission after treatment with intravenous polyvalent immunoglobulin in a weekly schedule followed by rituximab therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available